Breaking News

SCM To Manufacture Onco-Drug for SEP

Speciality European Pharma (SEP) and SCM Pharma have entered a manufacturing development agreement for the development and validation of the manufacturing and product testing processes at SCM’s UK-based facility.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Speciality European Pharma (SEP) and SCM Pharma have entered a manufacturing development agreement for the development and validation of the manufacturing and product testing processes at SCM’s UK-based facility. SEP initiated the transfer of the commercial supply of its oncology product Plenaxis to SCM Pharma. Once the development is complete, SCM is expected to be the exclusive production partner for the vial filling of SEP’s hormonal product for the treatment of advanced and metastatic prosta...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters